ℹ️ Compiled from public regulatory records · Last regulator revision: November 1, 2022🚩 Report this page
Silymarin
Liver Therapy
GB MHRA
- Drug class
- Liver Therapy
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Silymarin is an active pharmaceutical ingredient in the Liver Therapy group (A05BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | November 1, 2022 |
GBUnited Kingdom· MHRA
1 product
Uses
A traditional herbal medicinal product used to relieve the symptoms associated with occasional over indulgence of food and drink such as indigestion and upset stomach based on traditional use only.
How to take
Sources & citations
- [1]MHRA (UK) · THR333360005 · revised November 1, 2022
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.